E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/20/2014 in the Prospect News Convertibles Daily.

Midday Commentary: new National Health Investors trades around par; Jarden 1.875% convert in trade

By Rebecca Melvin

New York, March 20 - National Health Investors Inc.'s newly priced 3.25% convertibles were quoted at 100 bid, 100.5 offered with the underlying shares at $60.15, according to a syndicate source at late morning Thursday.

Meanwhile the company's shares were up 31 cents, or 0.5%. The bonds also printed lower at 99.5 in morning action.

The Murfreesboro, Tenn.-based health care real estate investment trust priced $175 million of the seven-year convertibles to yield 3.25% with an initial conversion premium of 20% after the close on Wednesday. Those terms were mixed compared to talk.

The new National Health issue was a primary focus of the early market. But Jarden Corp.'s 1.875% convertibles due 2018 remained somewhat active, recouping a little bit with the company's shares up 0.5% after having shaved some off on Wednesday. They traded around 141.

Before Jarden priced its latest issue of $600 million of 1.125% convertibles due 2034 earlier this month, the Jarden 1.875% convertibles had traded around the 145 mark.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.